Rating History for 6/30/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics
(H.C. Wainwright - Matthew Caufield) |
FDMT | Maintain | Buy (Buy) |
36.00 (N/A) |
|
Details | |||
| AAR Corporation
(KeyBanc - Michael Leshock) |
AIR | Downgrade | Sector Weight (Overweight) |
N/A (N/A) |
143.14 (132.61) |
-7.36% | Details | ||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 183 more... | |||||||||
